Neupro (Rotigotime)
Purpose of Medication and Method of Action
Neupro, available as a skin patch, is the first agent approved for Parkinson’s disease which is applied to the skin. Parkinson’s disease is believed to be due in part to a deficiency of dopamine in the brain. Neupro is a acts by stimulating dopaminergic receptors in the brain thus partially overcoming the relative lack of dopamine responsible for the symptoms of Parkinson’s disease.
Side Effects
Side effects include irritation at the application site, dizziness, drowsiness, and nausea.
Patient Medication Information
These information sheets do not list all known side effects of the medications, only the most common side effects. For a complete list of side effects please contact your local pharmacy or the actual drug manufacturing company.